05 July 2018 : Clinical Research
Radiological Changes Associated with New Bone Formation Following Osteotome Sinus Floor Elevation (OSFE): A Retrospective Study of 40 Patients with 18-Month Follow-Up
Jing Yang12ACDEF, Ting Xia1ABDEF, Ju Fang1ABF, Bin Shi1ADEFG*DOI: 10.12659/MSM.910739
Med Sci Monit 2018; 24: CLR4641-4648
Abstract
BACKGROUND: Osteotome sinus floor elevation (OSFE) is used to increase the bone volume at the site of the maxillary sinus through the transalveolar approach, and may require support with bone grafting. The aim of this retrospective study was to evaluate the radiological changes associated with new bone formation following OSFE during an 18-month follow-up period.
MATERIAL AND METHODS: Forty patients (including 51 implants) underwent OSFE with final dental reconstruction with a single crown, six months after surgery. Of the 51 dental implants, 24 were implanted with bone grafts, and 27 were implanted without bone grafts. All patients were reviewed using preoperative cone beam computed tomography (CBCT) and panoramic radiographs in postoperative follow-up immediately after OSFE, at six-month follow-up, at 12-month follow-up, and at 18-month follow-up. The degree of new bone formation following OSFE was measured by endo-sinus bone gain (ESBG) in the digital radiographs, and the related factors were analyzed.
RESULTS: At 18-month follow-up, the mean ESBG was 2.55±2.24 mm (range, 0.1–8.6 mm). Partial correlation analysis showed that there was no significant correlation between residual bone height (RBH) and ESBG (partial correlation coefficient –0.143) (P=0.328). There were significant positive correlations between the implant protrusion length (IPL) and ESBG (partial correlation coefficient 0.560) (P=0.000), and whether to perform bone grafts and ESBG (partial correlation coefficient 0.596) (P=0.000).
CONCLUSIONS: Following OSFE combined with a short implant, the IPL and the performance of bone grafts were significantly associated with new bone formation.
Keywords: Dental Implants, Sinus floor augmentation, Technology, Radiologic
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952